Skip to main
NHI

NHI Stock Forecast & Price Target

NHI Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 17%
Buy 50%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

National Health Investors is taking proactive steps to improve their long-term growth prospects and reduce their leverage by repositioning their portfolio through the sale of their entire National HealthCare Corporation (NHC) portfolio. This move will lower their initial annualized NOI, but also reduce their interest costs and provide them with approximately $500 million in dry powder to deploy into future acquisitions. With a reduced debt burden and a significant investment pipeline, NHI is well-positioned for above-average growth in the senior housing sector, making it an attractive investment opportunity.

Bears say

National Health Investors is expected to face challenges in the coming years as it sells off its predominantly skilled nursing portfolio and seeks to deploy the proceeds into more growth-oriented, senior housing operating portfolio assets. This will likely lead to lower FFO in the near-term and could result in a decrease in the stock's earnings multiple. Additionally, the potential for a competing bid for the portfolio remains uncertain, adding potential risk to the sale.

NHI has been analyzed by 6 analysts, with a consensus rating of Buy. 17% of analysts recommend a Strong Buy, 50% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Health Investors (NHI) Forecast

Analysts have given NHI a Buy based on their latest research and market trends.

According to 6 analysts, NHI has a Buy consensus rating as of Aug 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $83.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $83.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Health Investors (NHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.